LAURA RAY SHARP
Prescription History 1720547607
Nurse Practitioner in San Francisco, CA

Active since March 19, 2019PECOS EnrolledAccepts Medicare Assignment
201 SPEAR ST STE 230, SAN FRANCISCO, CA 94105(888) 663-6331(415) 252-7176 Get Directions

NPPES record last updated: June 5, 2024. Verified against the NPPES registry weekly; last sync: October 11, 2026.

Record update history: Jun 5, 2024, Mar 19, 2019 (2 updates tracked since 2019).

Medicare Part D Prescription History

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for LAURA RAY SHARP, an active Nurse Practitioner specialist practicing in San Francisco, CA. Our medical registry currently tracks 1 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 12 documented patient claims. Among these therapy options, the most frequently utilized medication is Novolin N Flexpen, which accounts for 12 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.

1
Medication
12
Total Claims
12
30-Day Fills
Novolin N Flexpen
Most Prescribed · 12 claims
View details
1 medication · 2023 Medicare Part D
Medicare Part D medications prescribed by LAURA RAY SHARP in 2023, with prescription volumes, average cost per fill, and CA state comparisons
Medication Prescriptions (2023)Rx (2023) Avg Cost per FillCost / Fill Vs. Other CA PrescribersVs. CA Avg
Novolin N FlexpenInsulin Nph Human Isophane12$57.71▼ below CA avg▼ Less than typical

About Novolin N Flexpen: Insulin isophane is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾

Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. This man-made insulin product is the same as human insulin. It replaces the insulin that your body would normally make. It is an intermediate-acting insulin (isophane). It starts to work more slowly but lasts longer than regular insulin. Insulin isophane works by helping blood sugar (glucose) get into cells so your body can use it for energy. Insulin isophane is often used in combination with a shorter-acting insulin. It may also be used alone or with other oral diabetes drugs (such as metformin).

In 2023, this provider wrote 12 Medicare prescriptions for Novolin N Flexpen, about 66% of the volume of the typical California prescriber of this medication (18.1). Medicare paid an average of $57.71 per fill, versus $107.08 statewide.

How often this provider prescribes it

This provider
12
CA average
18.1

This provider prescribes this medication less often than the average CA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$57.71
CA average
$107.08

This provider's average cost per fill is below the CA average for this medication.

12
30-Day Fills
standardized to 30-day supplies
192
Days of Medication
total across all patients in 2023
No medications match the current filters.
▲ More than typical≈ Typical▼ Less than typical= prescription volume vs the average CA prescriber of the same medication; volume reflects practice size as well as clinical preference.Green cost= below the CA average cost per fill.

About this data. The prescription history for LAURA RAY SHARP is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2023, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Nurse Practitioner prescribing approach at this San Francisco, CA practice.

Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average volume among CA prescribers of the same medication. Always confirm current medications and costs directly with the provider and your plan.